author · SDG 3

Publications by Srikanth Prasad Tripathy

Publications by Srikanth Prasad Tripathy at Dr. D. Y. Patil Vidyapeeth, Pune, aligned with SDG 3: Good Health and Well-being. 202 publications · page 2 of 11.

← All publications in SDG 3

1. Association of CC-chemokine ligand-2 gene polymorphisms with leprosy reactions
   Adjunct Faculties · National JALMA Institute for Leprosy & Other Mycobacterial Diseases · Microbes and Infection (2024)
2. Long-term follow-up of persons diagnosed with multidrug-resistant TB in Chennai, India, 2013–2020
   Central Research Facility · Indian Council of Medical Research · Dr. D. Y. Patil Medical College, Hospital and Research Centre · The International Journal of Tuberculosis and Lung Disease (2024)
3. A narrative review with a step-by-step guide to R software for clinicians: Navigating medical data analysis in cancer research
   Adjunct Faculties · Community Medicine · Dr. D.Y. Patil Vidyapeeth, Pune · Cancer Research Statistics and Treatment (2024)
4. Stigma, The Horrors of the Past: How Covid-19 Shaped Our Social Story?
   Central Research Facility · Dr. D.Y. Patil Vidyapeeth, Pune · Dr. D. Y. Patil Medical College, Hospital and Research Centre · National Journal of Community Medicine (2023)
5. Liquid Biopsy: A New Torchbearer in the Ever-Evolving Landscape of Breast Cancer Diagnosis
   Central Research Facility · Dr. D.Y. Patil Vidyapeeth, Pune · Dr. D. Y. Patil Medical College, Hospital and Research Centre · Asian Pacific Journal of Cancer Prevention (2023)
6. Prevalence of Tuberculosis Infection and Disease Among Homeless Persons Staying in NGO Shelters in Chennai
   Central Research Facility · National Institute of Research in Tuberculosis · Journal of Health Management (2023)
7. Next-Generation sequencing transforming clinical practice and precision medicine
   Central Research Facility · Community Medicine · Dr. D. Y. Patil Medical College, Hospital and Research Centre · Clinica Chimica Acta (2023)
8. Management of Nipah outbreak in India: A plea for immediate action
   Central Research Facility · Oral Pathology And Microbiology · Dr. D. Y. Patil Medical College, Hospital and Research Centre · Dr. D.Y. Patil Vidyapeeth, Pune · Dr D Y Patil Dental College & Hospital · Global Epidemiology (2023)
9. A Phase 3, randomized, non-inferiority study of a heterologous booster dose of SARS CoV-2 recombinant spike protein vaccine in adults
   Central Research Facility · Adjunct Faculties · Microbiology · Dr. D. Y. Patil Medical College, Hospital and Research Centre · Scientific Reports (2023)
10. Monocyte to lymphocyte ratio and hemoglobin level to predict tuberculosis after antiretroviral therapy initiation
    Central Research Facility · National AIDS Research Institute · AIDS (2023)
11. Association of human leukocyte antigen class I and class II alleles and haplotypes in COVID-19 infection in a western Indian population
    Adjunct Faculties · General Medicine · Dr. D. Y. Patil Medical College, Hospital and Research Centre · Infection, genetics and evolution (2023)
12. Neutralizing Antibodies against SARS-CoV2
    Microbiology · General Surgery · Central Research Facility · General Medicine · Dr. D.Y. Patil Vidyapeeth, Pune · Dr. D. Y. Patil Medical College, Hospital and Research Centre · Medical Journal of Dr D Y Patil Vidyapeeth (2023)
13. Lymphopenia with Altered T Cell Subsets in Hospitalized COVID-19 Patients in Pune, India
    Central Research Facility · Microbiology · Physiology · Adjunct Faculties · General Medicine · Respiratory Medicine · Community Medicine · Dr. D.Y. Patil Vidyapeeth, Pune · Dr. D. Y. Patil Medical College, Hospital and Research Centre · Viral Immunology (2023)
14. In-vivo studies on Transitmycin, a potent Mycobacterium tuberculosis inhibitor
    Central Research Facility · PLoS ONE (2023)
15. Safety and immunogenicity of SII-NVX-CoV2373 (COVID-19 vaccine) in adults in a phase 2/3, observer-blind, randomised, controlled study
    General Medicine · Adjunct Faculties · Microbiology · Dr. D. Y. Patil Medical College, Hospital and Research Centre · ˜The œLancet regional health. Southeast Asia (2023)
16. A study on individualized regimen for north Indians living with human immunodeficiency virus-1 subtype C: A public health approach
    Central Research Facility (2023)
17. Tuberculosis (TB) Aftermath: study protocol for a hybrid type I effectiveness-implementation non-inferiority randomized trial in India comparing two active case finding (ACF) strategies among individuals treated for TB and their household contacts
    Adjunct Faculties · Central Research Facility · Dr. D. Y. Patil Medical College, Hospital and Research Centre · Trials (2022)
18. Differential Frequencies of Intermediate Monocyte Subsets Among Individuals Infected With Drug-Sensitive or Drug-Resistant Mycobacterium tuberculosis
    Central Research Facility · National Institute of Research in Tuberculosis · Indian Council of Medical Research · Frontiers in Immunology (2022)
19. Genomic signatures of protease and reverse transcriptase genes from HIV-1 subtype C isolated from first-line ART patients in India
    Central Research Facility · National Institute of Research in Tuberculosis · Bioinformation (2022)
20. Mycobacterium tuberculosis Lineages Associated with Mutations and Drug Resistance in Isolates from India
    Central Research Facility · Indian Council of Medical Research · Microbiology Spectrum (2022)